Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.90% | -52.48% | 18.50% | 11.07% | 9.18% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -98.87% | 4.56% | -- | -- | -- |
| Total Other Non-Cash Items | 636.67% | 473.72% | -84.83% | -87.13% | -46.93% |
| Change in Net Operating Assets | 96.17% | -87.95% | 59.43% | 460.33% | 171.71% |
| Cash from Operations | 36.86% | 17.22% | 15.70% | 18.34% | 13.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -58.42% | -58.42% | 175.36% | 179.29% | 155.42% |
| Total Debt Repaid | -176.21% | -177.57% | -178.90% | -179.35% | -24.96% |
| Issuance of Common Stock | 5.03% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.56% | 405.42% | 26,080.88% | 4,274,900.00% | 3,211.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.30% | 99.63% | 98.91% | 78.53% | 74.37% |
